Aprazer Healthcare – Oncology Injection Manufacturer and Global Exporter
Aprazer Healthcare leads the way in the fight against cancer, combining scientific innovation and advanced technology to develop a range of high-quality oncology injectables.
- • More effective treatments.
- • Greater affordability.
- • Reliable access across the globe
- • Convenient dosage
Aprazer Healthcare – Leveraging Cutting–Edge Technology
Nanotechnology – the Nano formulation consists of nano particles that have better solubility and enhanced absorption, offering precision care.
- • Targeted action
- • Better bioavailability
- • Controlled drug release
- • Reduced side effects
Lyophilized freeze-dried solution – it is the process in which water content is removed through sublimation, and the drug is preserved to enhance longer shelf–life.
- • Better shelf life and stability
- • Easy to reconstitute
- • Easy to transport or carry
- • Maintains therapeutic efficacy
Doxorubicin Hydrochloride (Dorucin), Daunorubicin (Daunozer).
Ready-to-use injections
These are prefilled syringes that are sterilized and filled with the drug to a defined concentration, thereby reducing the risk of contamination.
- • easy administration
- • better dose accuracy
- • lesser contamination
Fulvestrant injection (Fulvekast), Gemcitabine (Apragem), Docetaxel(Docekast).
Aprazer’s Competitive Edge in Oncology Injections Manufacturing
An extensive oncology injection portfolio
Aparzer manufactures the widest range of generic oncology injection, including –
Dacarbazine (Dacarzer‑200 mg), Paclitaxel (Paclikast 300 mg), Cytarabine (Cytarzer), Etoposide (Posiact), Oxaliplatin (Oxazer), Docetaxel (Docekast),
World-class Manufacturing infrastructure
With continuous research and drug development, Aprazer Healthcare has global standard manufacturing facilities –
- • WHO-GMP certified manufacturing facilities.
- • Aseptic manufacturing and filling.
- • Advanced HVAC systems for environmental controls
- • Continuous batch process manufacturing
- • Stringent quality controls and monitoring
- • Genuine high-quality API
Global reach – the leading oncology injection exporter
Aprazer Healthcare, with its commitment to making healthcare accessible to all, reaches growing economies and is the leading exporter of oncology injections to over 50 countries.
South East Asia, South Africa, South America, and the CIS countries.
Global partnerships and collaborations
Aprazer Healthcare is a trusted global platform with strong logistics partners, offering temperature-controlled shipments and timely delivery.
We are collaborating with –
- • Leading pharmaceutical distributors
- • Leading hospitals
- • NGOS,
- • Oncology care centers
- • Medical centers
Regulatory Excellence
We evolve with the changing dynamics of the regulatory standards, aligning with the national regulatory authorities of the countries offering end-to-end regulatory support.
- • Product labeling and packaging standards for a specific country
- • Bioequivalent and stability support data
- • Product registration and market authorization
- • Regulatory audits and quality inspections
- • Pharmacovigilance systems
